ReviewCancer innovation2024

Leukocyte immunoglobulin-like receptor B4: A keystone in immune modulation and therapeutic target in cancer and beyond.

Qi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.